Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk.
Looking at options history for Novo Nordisk NVO we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish expectations and 11% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $152,884 and 13, calls, for a total amount of $691,331.
Predicted Price Range
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $85.0 to $155.0 for Novo Nordisk during the past quarter.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Novo Nordisk options trades today is 1121.0 with a total volume of 2,416.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Novo Nordisk's big money trades within a strike price range of $85.0 to $155.0 over the last 30 days.
Novo Nordisk Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | TRADE | NEUTRAL | 07/19/24 | $13.5 | $13.3 | $13.41 | $130.00 | $100.5K | 2.3K | 92 |
| NVO | CALL | TRADE | NEUTRAL | 01/17/25 | $37.8 | $37.35 | $37.6 | $110.00 | $90.2K | 726 | 24 |
| NVO | CALL | TRADE | BEARISH | 09/20/24 | $25.45 | $25.4 | $25.4 | $120.00 | $73.6K | 1.1K | 55 |
| NVO | CALL | TRADE | BULLISH | 06/21/24 | $4.35 | $4.25 | $4.35 | $140.00 | $65.2K | 4.6K | 200 |
| NVO | CALL | TRADE | BEARISH | 06/21/24 | $43.7 | $43.0 | $43.0 | $100.00 | $64.5K | 628 | 26 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
After a thorough review of the options trading surrounding Novo Nordisk, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Where Is Novo Nordisk Standing Right Now?
- With a volume of 3,098,102, the price of NVO is up 1.1% at $142.55.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 63 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novo Nordisk options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
